Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunitiesKaren D. Davis, Mary Ann Pelleymounter, Michael E. Burczynski et al.|Nature Reviews Neurology|2020Cited by 504
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s DiseaseRobert Martone, J. Steven Jacobsen, Hua Zhou et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 157
O3‐06‐07: GSI‐953 is a potent APP‐selective gamma‐secretase inhibitor for the treatment of Alzheimer's diseaseSteven J. Jacobsen, Robert Martone, Thomas A. Comery et al.|Alzheimer s & Dementia|2009Cited by 12